The purpose of this study is to find out what effects (good and bad) taking capecitabine for
12 weeks before surgery will have on women with breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Beth Israel Deaconess Medical Center Brigham and Women's Hospital Hoffmann-La Roche